Ken Alibek

EN Texto em inglês Ainda não há artigo no seu idioma: trecho em inglês.

Kanatzhan "Kanat" Baizakovich Alibekov (born 1950), known as Kenneth "Ken" Alibek since 1992, is a Kazakh-American microbiologist, bioweaponeer, and biological warfare administrative management expert. He was the first deputy director of Biopreparat. During his career in Soviet bioweaponry development in the late 1970s and 1980s, Alibekov managed projects that included weaponizing glanders and Marburg hemorrhagic fever, and created Russia's first tularemia bomb. His most prominent accomplishment was the creation of a new "battle strain" of anthrax, known as "Strain 836", later described by the Los Angeles Times as "the most virulent and vicious strain of anthrax known to man". In 1992, he immigrated to the United States; he has since become an American citizen and made his living as a biodefense consultant, speaker, and entrepreneur. He had actively participated in the development of biodefense strategy for the U.S. government, and between 1998 and 2005 he testified several times before the U.S. Congress and other governments on biotechnology issues, saying he was “convinced that Russia’s biological weapons program has not been completely dismantled”. In 1994, Alibek received a congressional award, a bronze Barkley medal awarded in recognition of distinguished public service and his contribution to world peace. In 2002, Alibek told United Press International that there is concern that monkeypox could be engineered into a biological weapon. Ohio-based Locus Fermentation Solutions hired Alibek in 2015 as executive vice president for research and development of biologically active molecules for different applications.